Literature DB >> 16409156

Cd4+Cd25+ regulatory T cells and their therapeutic potential.

David A Randolph1, C Garrison Fathman.   

Abstract

The human immune system mounts specific responses to a vast array of antigens. Although this is clearly beneficial in fighting off harmful infections and cancerous cells, the system must be carefully controlled to ensure that normal self-antigens are not targeted. A recently characterized subset of T cells, identified by their cell surface expression of CD4 and CD25, is critical in regulating the function of other immune cells and preventing potentially harmful autoimmune responses. This article reviews what is currently known about these so-called regulatory T cells and discusses the therapeutic potential of these cells to modulate human immune-based diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16409156     DOI: 10.1146/annurev.med.57.121304.131337

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  40 in total

1.  Engagement of TLR2 reverses the suppressor function of conjunctiva CD4+CD25+ regulatory T cells and promotes herpes simplex virus epitope-specific CD4+CD25- effector T cell responses.

Authors:  Gargi Dasgupta; Aziz Alami Chentoufi; Sylvaine You; Payam Falatoonzadeh; Lourie Ann A Urbano; Ayesha Akhtarmalik; Kimberly Nguyen; Lilit Ablabutyan; Anthony B Nesburn; Lbachir BenMohamed
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-17       Impact factor: 4.799

2.  Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial.

Authors:  Gadi Lalazar; Meir Mizrahi; Ilit Turgeman; Tomer Adar; Ami Ben Ya'acov; Yehudit Shabat; Assy Nimer; Nila Hemed; Lidya Zolotarovya; Yoav Lichtenstein; Nadya Lisovoder; Sarit Samira; Itamar Shalit; Ronald Ellis; Yaron Ilan
Journal:  J Clin Immunol       Date:  2015-04-17       Impact factor: 8.317

3.  Regulatory T cells interfere with glutathione metabolism in dendritic cells and T cells.

Authors:  Zhonghua Yan; Sanjay K Garg; Ruma Banerjee
Journal:  J Biol Chem       Date:  2010-10-30       Impact factor: 5.157

4.  Treatment with agonistic DR3 antibody results in expansion of donor Tregs and reduced graft-versus-host disease.

Authors:  Byung-Su Kim; Hidekazu Nishikii; Jeanette Baker; Antonio Pierini; Dominik Schneidawind; Yuqiong Pan; Andreas Beilhack; Chung-Gyu Park; Robert S Negrin
Journal:  Blood       Date:  2015-06-10       Impact factor: 22.113

5.  Induction of regulatory T cells decreases adipose inflammation and alleviates insulin resistance in ob/ob mice.

Authors:  Yaron Ilan; Ruth Maron; Ann-Marcia Tukpah; Tatiani Uceli Maioli; Gopal Murugaiyan; Kaiyong Yang; Henry Yim Wu; Howard L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-05       Impact factor: 11.205

Review 6.  The plasticity of human Treg and Th17 cells and its role in autoimmunity.

Authors:  Markus Kleinewietfeld; David A Hafler
Journal:  Semin Immunol       Date:  2013-11-05       Impact factor: 11.130

7.  B7 blockade alters the balance between regulatory T cells and tumor-reactive T cells for immunotherapy of cancer.

Authors:  Penghui Zhou; Xincheng Zheng; Huiming Zhang; Yang Liu; Pan Zheng
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

8.  Functional islet-specific Treg can be generated from CD4+CD25- T cells of healthy and type 1 diabetic subjects.

Authors:  S Alice Long; Mindi R Walker; Mary Rieck; Eddie James; William W Kwok; Srinath Sanda; Catherine Pihoker; Carla Greenbaum; Gerald T Nepom; Jane H Buckner
Journal:  Eur J Immunol       Date:  2009-02       Impact factor: 5.532

Review 9.  Application of cellular gene therapy for rheumatoid arthritis.

Authors:  Atsuo Nakajima
Journal:  Mod Rheumatol       Date:  2006       Impact factor: 3.023

10.  Cardiac myosin-Th17 responses promote heart failure in human myocarditis.

Authors:  Jennifer M Myers; Leslie T Cooper; David C Kem; Stavros Stavrakis; Stanley D Kosanke; Ethan M Shevach; DeLisa Fairweather; Julie A Stoner; Carol J Cox; Madeleine W Cunningham
Journal:  JCI Insight       Date:  2016-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.